Regenicin, Inc. (RGIN) financial statements (2022 and earlier)

Company profile

Business Address 10 HIGH COURT
LITTLE FALLS, NJ 07424
State of Incorp. NV
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments34113
Cash and cash equivalents34113
Total current assets:34113
Noncurrent Assets
Other undisclosed assets213554
TOTAL ASSETS:654556
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,5044,5693,8883,2782,696
Accounts payable85948913868
Accrued liabilities243235174144231
Employee-related liabilities4,1764,0313,4502,8692,288
Interest and dividends payable 209174127110
Debt1851851851010
Other undisclosed current liabilities428209219445350
Total current liabilities:5,1184,9624,2913,7333,056
Noncurrent Liabilities
Total liabilities:5,1184,9624,2913,7333,056
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,287)(4,958)(3,728)(3,728)(3,000)
Common stock158158158158158
Treasury stock, value(4)(4)   
Additional paid in capital10,20810,20810,20810,20810,178
Accumulated other comprehensive income    1
Retained earnings (accumulated deficit)15,47515,321(14,650)(14,090)(13,333)
Other undisclosed stockholders' equity attributable to parent(30,124)(30,640)556(4)(4)
Other undisclosed stockholders' equity(825) (560)  
Total stockholders' equity:(5,112)(4,958)(4,287)(3,728)(3,000)
TOTAL LIABILITIES AND EQUITY:654556

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Revenues
(Other Operating Income)
  153 249
Gross profit:  153 249
Operating expenses(707)(636) (737)(789)
Other operating expense, net
(Other Expenses)
(15)  (22)(19)
Other undisclosed operating income (loss)15 (664)2219
Operating loss:(707)(636)(511)(737)(540)
Nonoperating income
(Investment Income, Nonoperating)
3    
Interest and debt expense10335106(18)230
Net loss:(602)(601)(405)(755)(310)
Other undisclosed net income (loss) attributable to parent(137)(69)9651,513(249)
Net income (loss) attributable to parent:(739)(671)560758(559)
Other undisclosed net loss available to common stockholders, basic(71)(70)(1,190)(1,588) 
Net loss available to common stockholders, diluted:(809)(741)(631)(829)(559)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Net loss:(602)(601)(405)(755)(310)
Comprehensive loss:(602)(601)(405)(755)(310)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (248)
Comprehensive loss, net of tax, attributable to parent:(602)(601)(405)(755)(559)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: